Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
4.000
0.00 (0.00%)
At close: May 18, 2026, 4:00 PM EDT
3.900
-0.100 (-2.50%)
Pre-market: May 19, 2026, 4:32 AM EDT
Tvardi Therapeutics Employees
Tvardi Therapeutics had 12 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
12
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,286,583
Market Cap
37.53M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 12 | 0 | - |
| Dec 31, 2024 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Aligos Therapeutics | 82 |
| NextCure | 40 |
| Mereo BioPharma Group | 39 |
| Plus Therapeutics | 28 |
| Actinium Pharmaceuticals | 25 |
| INmune Bio | 21 |
| Veru Inc. | 20 |
TVRD News
- 11 days ago - Tvardi Therapeutics reports Q1 EPS (73c), consensus (72c) - TheFly
- 11 days ago - Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update - GlobeNewsWire
- 17 days ago - Tvardi Therapeutics files $200M mixed securities shelf - TheFly
- 4 weeks ago - Tvardi Therapeutics downgraded to Underweight from Equal Weight at Barclays - TheFly
- 6 weeks ago - Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium - GlobeNewsWire
- 6 weeks ago - Tvardi Therapeutics price target lowered to $3 from $4 at Piper Sandler - TheFly
- 6 weeks ago - Tvardi Therapeutics price target lowered to $4 from $5 at Barclays - TheFly
- 6 weeks ago - Tvardi Therapeutics reports Q4 EPS (78c), consensus (57c) - TheFly